Received Oct 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Soreness; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain (Verbatim: Soreness). The outcome of the pain was unknown. The reporter considered the pain to be related to Shingrix. The company considered the pain to be related to Shingrix. Additional Information: GSK Receipt Date: 05-OCT-2025 This case was reported by a patient via interactive digital media. The patient self-reported the case for herself. She mentioned that she had received two shots and it was not that bad, just soreness. The patient's daughter had gotten shingles at the young age of 32 years. It had been horrible for her (patient's daughter) but did not last a long time. The patient had requested people to get vaccines, as it was worth it. The batch number was not provided, and we are unable to contact the reporter.